Financhill
Back

Ultragenyx Pharmaceutical, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$34.43
Seasonality Move:
-0.96%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Ultragenyx Pharmaceutical, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 34.66 Buy
20-day SMA: 34.85 Sell
50-day SMA: 33.8 Buy
200-day SMA: 33.55 Buy
8-day EMA: 21.4 Buy
20-day EMA: 11.1 Buy
50-day EMA: 4.97 Buy
200-day EMA: 1.32 Buy

Ultragenyx Pharmaceutical, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.51 Buy
Relative Strength Index (14 RSI): 52.34 Buy
Chaikin Money Flow: 1445075 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.72 - 36) Buy
Bollinger Bands (100): (29.28 - 34.24) Buy

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Ultragenyx Pharmaceutical, Inc. Stock

Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?

RARE Technical Analysis vs Fundamental Analysis

Sell
37
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy or a Sell?

Ultragenyx Pharmaceutical, Inc. Stock Info

Market Cap:
3.4B
Price in USD:
34.75
Share Volume:
2.3M

Ultragenyx Pharmaceutical, Inc. 52-Week Range

52-Week High:
46.50
52-Week Low:
25.81
Sell
37
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Ultragenyx Pharmaceutical, Inc. Share Price Forecast

Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?

Fundamental Analysis of Ultragenyx Pharmaceutical, Inc.

Is Ultragenyx Pharmaceutical, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Technical Analysis of Ultragenyx Pharmaceutical, Inc.

Should I short Ultragenyx Pharmaceutical, Inc. stock?

* Ultragenyx Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.